Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01962
Species: Homo sapiens
Position : chr5:149631000-149636000
Year: 2022
Title: TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: breast carcinoma
PMID:  34718356
MONDO: MONDO:0004989
Tissue: breast
Tissue Ontology ID: UBERON:0000310
Cell Source: Human breast cancer cell
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, TF binding assay, Functional perturbation assay
High Throughput Method: ChIP-seq; RNA-seq; DNase-seq
Low Throughput Method: Luciferase Reporter Assay; ChIP-RT-qPCR; CRISPR knockout; RT-RT-qPCR; Western blot
About Target Gene
Target gene : TCOF1
About TF
TF name : MYBL2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
MYBL2 E2F transcription factor network pid 77
MYBL2 G0 and Early G1 reactome 25
MYBL2 Polo-like kinase mediated events reactome 16
MYBL2 Hs_Gastric_Cancer_Network_1_WP2361_86831 wikipathways 26
MYBL2 Hs_EGF-EGFR_Signaling_Pathway_WP437_79266 wikipathways 107
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_01961 chr5:149631000-149636000 breast malignant cell breast carcinoma
E_01963 chr5:149631000-149636000 breast malignant cell breast carcinoma
E_01964 chr5:149631000-149636000 breast malignant cell breast carcinoma
Expression of Target Genes for the Enhancer